University of Kansas
Liang Xu is a professor in the Department of Molecular Bioscience in University od Kansas. The goal of the proposed research is to establish nanovectors as a gene/miRNA delivery platform to develop novel molecular therapies targeting cancer stem cells. In summary he has a demonstrated record of successful and productive research projects relevant to the his research field and his expertise and experience have prepared him to go for invention of a new direction in cancer research.
Molecular therapy targeting cancer and cancer stem cells, cancer biology, drug discovery and drug/gene delivery.(Funded by multiple NIH and DOD grants). Molecularly targeted cancer therapy and chemo/radiosensitization by modulating cell death signaling pathways, autophagy and apoptosis. Exploring microRNAs as novel targets for cancer and cancer stem cells. Nanovectors targeting cancer cells for siRNA/miRNA-based novel cancer therapeutics. Nanovectors targeting cancer stem cells and exploring novel molecular therapy for cancer stem cells.